奇卓然, 杜晓静, 杨毕伟, 曹鑫, & 夏景林. (2023). 肝细胞癌仑伐替尼耐药机制与新治疗策略. 中国临床医学, 30(2), 335-342. https://doi.org/10.12025/j.issn.1008-6358.2023.20220071
Chicago Style (17th ed.) Citation奇卓然, 杜晓静, 杨毕伟, 曹鑫, and 夏景林. "肝细胞癌仑伐替尼耐药机制与新治疗策略." 中国临床医学 30, no. 2 (2023): 335-342. https://doi.org/10.12025/j.issn.1008-6358.2023.20220071.
MLA (9th ed.) Citation奇卓然, et al. "肝细胞癌仑伐替尼耐药机制与新治疗策略." 中国临床医学, vol. 30, no. 2, 2023, pp. 335-342, https://doi.org/10.12025/j.issn.1008-6358.2023.20220071.
Warning: These citations may not always be 100% accurate.